NCT07489092

Brief Summary

This study aims to evaluate the feasibility, usability, and clinical effectiveness of a digital rehabilitation platform in adult patients discharged from the intensive care unit (ICU). Adult patients aged 19 years or older who stayed in the ICU for more than 48 hours and are capable of using a smartphone will be enrolled from two tertiary hospitals in South Korea. Participants will receive individualized rehabilitation programs using a digital rehabilitation platform ("Tuntun Rehabilitation Assistant") based on their functional status. Rehabilitation will be conducted once daily for up to 30 minutes per session. Physical and cognitive function outcomes will be assessed at baseline, two weeks after intervention initiation, at hospital discharge, and during follow-up when applicable. This prospective cohort study will investigate changes in physical function, mobility, cognitive status, and quality of life, as well as platform usage and safety-related events, to determine the clinical usefulness of digital rehabilitation for ICU survivors.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
5mo left

Started Feb 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Feb 2026Dec 2026

First Submitted

Initial submission to the registry

January 13, 2026

Completed
20 days until next milestone

Study Start

First participant enrolled

February 2, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 23, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

March 23, 2026

Status Verified

March 1, 2026

Enrollment Period

11 months

First QC Date

January 13, 2026

Last Update Submit

March 19, 2026

Conditions

Keywords

Intensive Care Unit Acquired weaknessDigital Therapeutics

Outcome Measures

Primary Outcomes (8)

  • Medical Research Council Sum Score (MRC-SS)

    Summation score of muscle strength based on MRC scale. Unit of Measure: Sum score (0 to 60, where a higher score indicates better overall muscle strength.)

    From enrollment to the end of treatment at 2 weeks

  • Functional Ambulatory Category (FAC)

    Measurement of the level of ambulation and assistance required. Unit of Measure: FAC score (0 to 5, where a higher score indicates greater walking independence.)

    From enrollment to the end of treatment at 2 weeks

  • Mini-Mental State Examination (MMSE)

    Cognitive function assessment using the MMSE tool. Unit of Measure: MMSE score (0 to 30, where a higher score indicates better cognitive function.)

    From enrollment to the end of treatment at 2 weeks

  • EQ-5D-5L

    Assessment of patient-reported quality of life using the EQ-5D-5L questionnaire, which includes five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), each rated on a 5-level scale. Responses were converted to a utility index score. Unit of Measure: Utility score (0 to 1).

    From enrollment to the end of treatment at 2 weeks

  • EQ-5D VAS

    Assessment of patient-reported quality of life using the EQ-5D visual analog scale (VAS), where participants rate their overall health on a scale from 0 (worst imaginable health) to 100 (best imaginable health). Unit of Measure: VAS score (0 to 100).

    From enrollment to the end of treatment at 2 weeks

  • SLR time

    Assessment of straight leg raise (SLR) repetitions over 60 seconds and static holding ability. Unit of Measure: time (seconds) (For time: A higher value indicates better static endurance.)

    From enrollment to the end of treatment at 2 weeks

  • SLR count

    Assessment of straight leg raise (SLR) repetitions performed within 60 seconds. Unit of Measure: Count (repetitions) (For count: A higher value indicates better performance.)

    From enrollment to the end of treatment at 2 weeks

  • Short Physical Performance Battery (SPPB) Total Score

    Assessment of lower extremity physical performance using the Short Physical Performance Battery (SPPB), which includes balance tests, gait speed, and repeated chair stand tests. Scores range from 0 to 12, with higher scores indicating better physical performance. Unit of Measure: Total score (0 to 12).

    From enrollment to the end of treatment at 2 weeks

Study Arms (1)

Digital Rehabilitation Group

EXPERIMENTAL
Device: Digital Rehabilitation Group

Interventions

The Tuntun Rehabilitation Assistant is a smartphone-based digital rehabilitation platform designed for patients discharged from the intensive care unit. Rehabilitation sessions are conducted once daily, with each session lasting up to 30 minutes. During the initial five sessions, a researcher assists participants in performing the intervention in the hospital room. Thereafter, participants independently perform the prescribed exercises using the digital platform. The intervention is continued during hospitalization and, when applicable, after discharge until outpatient follow-up.

Digital Rehabilitation Group

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 19 years or older.
  • Admission to the intensive care unit (ICU) for more than 48 hours.
  • Hospitalization at Asan Medical Center or Seoul National University Bundang Hospital.
  • Discharge from the ICU at the time of enrollment.
  • Ownership of a smartphone and ability to operate a digital rehabilitation platform.
  • Ability to understand the study procedures and provide voluntary written informed consent.

You may not qualify if:

  • Medical conditions that contraindicate participation in rehabilitation exercise, as determined by the attending physician.
  • Severe cognitive impairment or communication difficulties that interfere with understanding or following study instructions.
  • Unstable medical conditions requiring ongoing intensive medical treatment.
  • Inability to use a smartphone or digital platform independently.
  • Refusal to participate or withdrawal of informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asan Medical Center

Seoul, South Korea

RECRUITING

Central Study Contacts

Won Kim, Associate professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 13, 2026

First Posted

March 23, 2026

Study Start

February 2, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

March 23, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

All individual patient data (IPD) used in this study will be handled in compliance with domestic privacy protection laws and relevant regulations. The privacy of study participants will be strictly safeguarded, and their personal information will not be used for purposes other than the study. When sharing data, only de-identified data that has been approved by the researchers after adequate request will be provided, and privacy protection and security will be prioritized throughout the process.

Locations